<DOC>
	<DOCNO>NCT00111670</DOCNO>
	<brief_summary>This study ass efficacy , safety tolerability DPP-IV Inhibitor compare placebo patient type 2 diabetes . The anticipated time study treatment &lt; 3 month target sample size 100-500 individual .</brief_summary>
	<brief_title>A Study DPP-IV Inhibitor Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>adult patient 1875 year age ; type 2 diabetes diagnose &gt; =1 month screening ; previous treatment , previous treatment 2 oral medication . type 1 diabetes ; type 2 diabetes treat insulin PPAR gamma agonist 3 month screen ; patient pregnant , breastfeed use reliable contraceptive method .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>